Pharmyn ApS: Financial statements 2022
CVR: 37133892
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -19,740 and a net result of DKK -19,953 compared with DKK 12,244 the year before. Equity in the 2022 report amounted to DKK 13,941. The solvency ratio was 44.8%.
- Gross Profit
- DKK -19,740
- Profit/Loss
- DKK -19,953
- Equity
- DKK 13,941
- Total Assets
- DKK 31,138
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
| 2019 | - | 108 | 0 | 42 t. | 1 |
| 2018 | - | 288 | 88 | 42 t. | 0 |
Official annual report
Keep an eye on Pharmyn ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmyn ApS has published its annual report for 2021. Gross profit came to DKK 12,488, and the net result was DKK 12,244.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.